Skip to content

Early diagnosis of colorectal cancer by faecal occult blood detection - the Goteborg trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58825135
Enrollment
68000
Registered
2007-09-11
Start date
1982-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer Cancer Colorectal cancer

Interventions

Intervention: detection of faecal blood by Haemoccult analyses of samples from three consecutive stools, in the group randomised to "screening" Control: no contact/information If blood was detected,

Sponsors

Swedish Cancer Society (Sweden)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The entire population was born between 1918 and 1931, men and women, in Goteborg, Sweden. Only those randomised to "intervention, i.e., screening for occult faecal blood" were invited to participate, the control group was not contacted. Initial invitation to the trial was when each individual was between the ages of 60 to 64 years, thus inclusion from 1982 to 1995 in cohorts of five years.

Exclusion criteria

Exclusion criteria: Does not meet the above criteria.

Design outcomes

Primary

MeasureTime frame
Mortality in colorectal cancer. Time points were: after invitation, after screening participation, after work-up of positive screen test and after treatment for patients with positive work-up.

Secondary

MeasureTime frame
1. Overall mortality 2. Quality of life 3. Sensitivity and specificity of screening procedure 4. Sensitivity and specificity of work up procedure 5. Stage distribution of adenomas and cancers The questionnaires used were specifically designed for this trial, with face validation and tested in pilot populations before use. Time points were: after invitation, after screening participation, after work-up of positive screen test and after treatment for patients with positive work-up.

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026